A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal Class II furcation involvement in mandibular molars. Part I: Study design and results for primary outcomes.
Jepsen
Søren
S
Department of Periodontology, University of Bonn, Bonn, Germany. jepsen@uni-bonn.de
Heinz
Bernd
B
Jepsen
Karin
K
Arjomand
Mehrdad
M
Hoffmann
Thomas
T
Richter
Steffen
S
Reich
Elmar
E
Sculean
Anton
A
Gonzales
José R
JR
Bödeker
Rolf H
RH
Meyle
Jörg
J
D020341:Absorbable Implants; D000328:Adult; D000368:Aged; D003746:Dental Enamel Proteins / Q000627:therapeutic use*; D005260:Female; D017823:Furcation Defects / Q000601:surgery*; D016557:Guided Tissue Regeneration, Periodontal / Q000379:methods*; D006801:Humans; D008297:Male; D008334:Mandible; D008567:Membranes, Artificial; D008875:Middle Aged; D008963:Molar / Q000473:pathology; D019647:Oral Surgical Procedures / Q000379:methods*; D010512:Periodontal Index; D011182:Postoperative Care; D012107:Research Design; D018401:Sample Size; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
D003746:Dental Enamel Proteins; D008567:Membranes, Artificial; C109069:enamel matrix proteins